FY2026 · ended Jul 31, 2026 · Revenue $874,000, +2813.3% YoY · Filed Oct 29, 2026
Rafael Holdings, Inc. (RFL) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2026, which ended Jul 31, 2026, it reported revenue of $874,000 and a net loss of $29.6 million. Free cash flow was -$30.0 million.
Revenue
$874,000
+2813.3% vs prior year
Net income
$-29.64M
+2.9% vs prior year
Operating cash flow
$-29.99M
-58.5% vs prior year
Free cash flow
$-29.99M
-58.4% vs prior year
EPS
$-0.58
+44.2% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
-3822.5%
FY 2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RFL (NYSE)
- Fiscal year ends
- July 31
- Incorporated in
- DE
- Headquarters
- Newark, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1713863
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2026 Jul 31, 2026 |
FY 2025 Jul 31, 2025 |
FY 2024 Jul 31, 2024 |
FY 2023 Jul 31, 2023 |
FY 2022 Jul 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $874,000 | $30,000 | $637,000 | $279,000 | $410,000 |
| Operating income | -$33.4M | -$29.2M | -$102.6M | -$15.0M | -$60.5M |
| Net income | -$29.6M | -$30.5M | -$34.4M | -$1.9M | -$124.7M |
| Diluted EPS | -$0.58 | -$1.04 | -$1.45 | -$0.08 | -$6.31 |
| Operating cash flow | -$30.0M | -$18.9M | -$7.8M | -$10.9M | -$26.1M |
| Free cash flow | -$30.0M | -$18.9M | -$7.9M | — | -$26.1M |
| Total assets | $83.1M | $114.1M | $96.8M | $98.8M | $118.3M |
| Total liabilities | $11.1M | $15.7M | $10.6M | $2.2M | $21.1M |
| Stockholders' equity | $66.3M | $94.4M | $82.2M | $100.3M | $100.5M |
| Cash and investments | $22.9M | $52.8M | $65.9M | $79.2M | $63.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Oct 29, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 8, 2026 | Jul 8, 2026 |
| 10-Q | Quarterly report | Jun 11, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jun 11, 2026 | Jun 11, 2026 |
All 409 Rafael Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.